Literature DB >> 6431335

Intracranial self-stimulation distinguishes between two benzodiazepine antagonists.

S Pellow, S E File, L J Herberg.   

Abstract

Low doses of Ro 15-1788 and CGS 8216 were without effect on variable-interval self-stimulation, but completely abolished the enhancement of responding produced by chlordiazepoxide (5 mg/kg). Higher doses of Ro 15-1788, unlike other benzodiazepine receptor antagonists, produced an increase in response rates similar to that found after chlordiazepoxide. This result is consistent with its suggested action as a partial agonist. The combination of a high (benzodiazepine-like) dose of Ro 15-1788 with chlordiazepoxide produced a depression of responding similar to that seen with high doses of benzodiazepines. High doses of CGS 8216 produced a depression of self-stimulation, which was not reversed by chlordiazepoxide (5 mg/kg). Thus, the present procedure is able to distinguish contrasting behavioural effects of benzodiazepine antagonists.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431335     DOI: 10.1016/0304-3940(84)90425-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  The benzodiazepine antagonist CGS 8216 decreases both shocked and unshocked drinking in rats.

Authors:  D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats.

Authors:  S J Cooper; D J Barber; D B Gilbert; W R Moores
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: interactions with Ro 15-1788.

Authors:  S E File; S Pellow; L H Jensen
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Effect on hypothalamic self-stimulation of the novel beta-carbolines ZK 93 426 (a benzodiazepine receptor antagonist) and ZK 91 296 (a putative partial agonist).

Authors:  L J Herberg; A M Montgomery; S E File; S Pellow; D N Stephens
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 6.  Multiple sites of action for anxiogenic drugs: behavioural, electrophysiological and biochemical correlations.

Authors:  S Pellow; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Benzodiazepine-induced hyperphagia: stereospecificity and antagonism by pyrazoloquinolines, CGS 9895 and CGS 9896.

Authors:  S J Cooper; R E Yerbury
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice.

Authors:  R J Rodgers; J I Randall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 9.  Flumazenil. A preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use.

Authors:  R N Brogden; K L Goa
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

10.  Learnt tolerance to sedative effects of chlordiazepoxide on self-stimulation performance, but no tolerance to facilitatory effects after 80 days.

Authors:  L J Herberg; A M Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.